Clinical Trial

Efficacy and Safety of ZSP1273 in Children 12-17 Years Old With Influenza A

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated December 16, 2025 (before its estimated December 22, 2025 completion). Its status may not reflect the trial's current state.
Summary
This trial is conducted in China. This is a multi-center, randomized, double-blind, placebo-controlled clinical trial to assess the efficacy and safety of ZSP1273 in the treatment of Acute Uncomplicated influenza A in adolescents.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-13; most recent amendment 2025-12-08.
Status change: Recruiting → Active, Not Recruiting 2025-12-08
Trial Details
NCT Number NCT07229820
Lead Sponsor Guangdong Raynovent Biotech Co., Ltd
Conditions Influenza A
Enrollment 157 participants
Start Date 2025-11-08
Primary Completion 2025-12-22 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-16